title: Bisacodyl plus split 2-L polyethylene glycol-citrate-simethicone improves quality of bowel preparation before screening colonoscopy.
abstract: OBJECTIVE
  To compare the bowel cleansing efficacy, tolerability and acceptability of split 2-L polyethylene glycol (PEG)-citrate-simethicone (PEG-CS) plus bisacodyl (BIS) vs 4-L PEG for fecal occult blood test-positive screening colonoscopy.
  
  
  METHODS
  This was a randomised, observer-blind comparative study. Two hundred and sixty-four subjects underwent screening colonoscopy (mean age 62.5 ± 7.4 years, male 61.7%). The primary objective of the study was to compare the bowel cleansing efficacy of the two preparations.
  
  
  METHODS
  BIS plus PEG-CS: 3 tablets of 5-mg BIS at 16:00, PEG-CS 1-L at 19:00 and 1-L at 7:00, 4-L PEG: 3-L at 17:00, and 1-L at 7:00. Colonoscopy was carried out after 11:00, at least 3 h after the completion of bowel preparation. Bowel cleansing was evaluated using the Harefield Cleansing Scale.
  
  
  RESULTS
  Bowel preparation was successful for 92.8% of subjects in the PEG-CS group and for 92.1% of subjects in the 4-L PEG (RR = 1.01; 95%CI: 0.94-1.08). BIS + PEG-CS was better tolerated than 4-L PEG. A greater rate of patients in the BIS + PEG-CS group had no difficulty and/or were willing to repeat the same preparation compared to split-dose 4-L PEG group. Subjects in the BIS + PEG-CS group rated the prep as good or satisfactory in 90.6% as compared to 77% in the 4-L PEG (P = 0.003). Subjects receiving BIS + PEG-CS stated they fully adhered to instructions drinking all the 2-L solution in 97.1% compared with 87.3% in the 4-L PEG (P = 0.003).
  
  
  CONCLUSIONS
  BIS plus split 2-L PEG-CS was as effective as but better tolerated and accepted than split 4-L PEG for screening colonoscopy. This new procedure may increase the positive attitude and participation to colorectal cancer screening colonoscopy.
authors.affiliation: Flavio Valiante, Angelo Bellumat, Manuela De Bona, Michele De Boni, Department of Gastroenterology and Digestive Endoscopy, S Maria del Prato Hospital, Feltre, 32032 Belluno, Italy.
authors.forename: Flavio
authors.initials: F
authors.lastname: Valiante
authors.forename: Angelo
authors.initials: A
authors.lastname: Bellumat
authors.forename: Manuela
authors.initials: M
authors.lastname: De Bona
authors.forename: Michele
authors.initials: M
authors.lastname: De Boni
mesh_terms: D000368:Aged; D001726:Bisacodyl / Q000008:administration & dosage*; D002400:Cathartics / Q000008:administration & dosage*; D019343:Citric Acid / Q000008:administration & dosage*; D003113:Colonoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011189:Potassium Chloride / Q000008:administration & dosage*; D012841:Simethicone / Q000008:administration & dosage*; D012965:Sodium Chloride / Q000008:administration & dosage*
chemical_list: D002400:Cathartics; D001726:Bisacodyl; D019343:Citric Acid; D011092:Polyethylene Glycols; D012965:Sodium Chloride; D011189:Potassium Chloride; D012841:Simethicone
keywords: Bisacodyl; Bowel preparations; Colon cleansing; Colonoscopy; Polyethylene glycol; Simethicone
references.citation: Am J Health Syst Pharm. 2009 Jan 1;66(1):27-37
references.pmid: 19106342
references.citation: Gastrointest Endosc. 2012 Jun;75(6):1197-203
references.pmid: 22381531
references.citation: Gastrointest Endosc. 2011 Jun;73(6):1207-14
references.pmid: 21481857
references.citation: Int J Cancer. 2012 Oct 1;131(7):1649-58
references.pmid: 21607946
references.citation: Epidemiol Prev. 2009 May-Jun;33(3 Suppl 2):57-74
references.pmid: 19776487
references.citation: Dig Liver Dis. 2013 Jan;45(1):23-7
references.pmid: 22917636
references.citation: World J Gastroenterol. 2006 Oct 14;12(38):6161-6
references.pmid: 17036388
references.citation: Gastrointest Endosc. 2003 Jul;58(1):36-40
references.pmid: 12838218
references.citation: Gastrointest Endosc. 2013 Jul;78(1):121-31
references.pmid: 23531426
references.citation: Dig Liver Dis. 2012 Jul;44(7):576-9
references.pmid: 22456624
references.citation: Ann Intern Med. 2011 Jan 4;154(1):22-30
references.pmid: 21200035
references.citation: N Engl J Med. 2012 Feb 23;366(8):687-96
references.pmid: 22356322
references.citation: Dig Liver Dis. 2012 Mar;44(3):224-7
references.pmid: 22119219
references.citation: Gastrointest Endosc. 2010 Aug;72(2):313-20
references.pmid: 20561621
references.citation: Gastrointest Endosc. 2009 Mar;69(3 Pt 2):700-6
references.pmid: 19251013
references.citation: Gastrointest Endosc. 2003 Jul;58(1):76-9
references.pmid: 12838225
references.citation: Am J Gastroenterol. 2003 Oct;98(10):2187-91
references.pmid: 14572566
references.citation: Aliment Pharmacol Ther. 2012 Oct;36(8):717-24
references.pmid: 22924336
references.citation: Gastrointest Endosc. 2005 Aug;62(2):213-8
references.pmid: 16046981
references.citation: Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1321-5
references.pmid: 19950784
references.citation: Gastrointest Endosc. 2006 Jun;63(7):894-909
references.pmid: 16733101
references.citation: Am J Gastroenterol. 2011 Nov;106(11):1986-93
references.pmid: 21670773
references.citation: Aliment Pharmacol Ther. 1993 Dec;7(6):655-9
references.pmid: 8161673
references.citation: Gastrointest Endosc. 2005 Mar;61(3):378-84
references.pmid: 15758907
references.citation: Am J Gastroenterol. 2009 Mar;104(3):739-50
references.pmid: 19240699
references.citation: Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):557-64
references.pmid: 20736921
references.citation: Scand J Gastroenterol. 2011 Feb;46(2):227-35
references.pmid: 20977386
references.citation: Gastrointest Endosc. 1988 May-Jun;34(3):255-8
references.pmid: 3292345
references.citation: Gastrointest Endosc. 2010 Aug;72(2):406-12
references.pmid: 20579994